Sternberk, Czechia

Radek Melnický

This inventor holds 1 USPTO granted patent. Top assignee: Hameln Pharma Plus Gmbh. Active years: 2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Radek Melnický. Retrieved from https://idiyas.com/inventor/radek-melnický

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2016

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Radek Melnický: Innovator in Pharmaceutical Chemistry

Introduction

Radek Melnický is a notable inventor based in Sternberk, Czech Republic. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of new compounds. His work has led to the creation of innovative solutions that enhance medical treatments.

Latest Patents

Radek Melnický holds a patent for the crystalline forms of zinc trisodium pentetic acid. This invention relates to the production of zinc trisodium pentetic acid (Zn-DTPA) and introduces new crystalline forms of this important salt. His patent is a testament to his expertise and dedication to advancing pharmaceutical science. He has 1 patent to his name.

Career Highlights

Melnický is currently employed at Hameln Pharma Plus GmbH, where he continues to work on innovative pharmaceutical solutions. His role at the company allows him to apply his knowledge and skills in a practical setting, contributing to the development of effective medical products.

Collaborations

Throughout his career, Radek has collaborated with talented professionals in the field. Notable coworkers include Christian Schickaneder and Vendel Smahovský, who have worked alongside him on various projects, enhancing the impact of their collective expertise.

Conclusion

Radek Melnický is a distinguished inventor whose work in pharmaceutical chemistry has led to significant advancements in medical treatments. His contributions, particularly in the area of zinc trisodium pentetic acid, highlight his commitment to innovation and excellence in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…